Bolton Medical Receives CE Mark for TREO® Abdominal Stent-Graft System

-- European Launch Scheduled for January 2016 --

Sep 24, 2015, 12:58 ET from Bolton Medical

SUNRISE, Fla., Sept. 24, 2015 /PRNewswire/ -- Bolton Medical, a subsidiary of the WerfenLife Company, received CE Mark for the TREO® Abdominal Stent-Graft System used to treat abdominal aortic aneurysms (AAAs). TREO is the latest advancement in endovascular aneurysm repair (EVAR), embodying the best technology available on the market.

Every aspect of the TREO Abdominal Stent-Graft System is designed to provide both the patient and physician confidence in the treatment of AAAs.  Modularly designed as a three-piece system, TREO offers a wide range of sizes that allow for precise treatment and greater patient applicability.  As the only EVAR solution with dual proximal fixation and a unique proximal clasping mechanism, TREO was engineered to allow for accurate and controlled deployment and provide long-term stability of the stent-graft.

"We believe that in EVAR, the tri-modular strategy is the best approach," said Scott Rush, Vice President of Research & Development.  "This is because it allows you to deliver a tailored solution to each patient by selecting specific components to precisely work in that individual anatomy."

"Stent migration and endoleaks are major concerns in EVAR," said John Henretta, M.D., Carolina Vascular.  "The TREO stent-graft offers both suprarenal and infrarenal fixation, distributing the attachment points in two different anatomical levels, which may work to reduce potential  endoleaks, particularly in angulated necks.  I expect this to lower re-intervention rates in my practice."

Bolton Medical will begin a limited market release of TREO with selected customers in Europe beginning in October and will officially launch TREO at the Leipzig Interventional Course in January 2016.

"We are looking forward to sharing the TREO technology with a global audience in January," said Paul Kuznik, Chief Executive Officer.  "We will showcase the technology with deployment demonstrations at our booth, expert panel discussions, and live case presentations."

TREO is the latest addition to the Bolton Medical's abdominal product portfolio.  Additional product information is available at

About Bolton Medical
Bolton Medical is a subsidiary of the WerfenLife Company.  WerfenLife is a global company that manufactures and distributes medical diagnostic solutions and medical devices worldwide.  Headquartered in the U.S., Bolton Medical improves the quality of patient care by developing, manufacturing, and distributing innovative, high-quality products and technology solely focused on the aorta. 

Megan Eckerman
Vice President of Marketing

Latoya Spencer
Marketing Communications

Logo -

SOURCE Bolton Medical